Mithra, a Belgian biotech company dedicated to women’s health, held its annual General Meeting yesterday and elected its new Board of Directors. HOYNG ROKH MONEGIER’s Brussels partner Liesbeth Weynants who has extensive expertise in IP and pharmaceutical regulatory law will join as one of the 4 newly appointed directors.
The new board has a perfect parity between men and women as well as dependent and independent directors. The directors have varied and complementary profiles in all fields covering pharmaceutical products development.
https://investors.mithra.com/wp-content/uploads/2021/05/2021-05-20-New-Board-of-Directors-EN.pdf
